2cureX AB announced that Professor Andrew Beggs, from Queen Elizabeth Hospital Birmingham (QEHB) and University of Birmingham, UK has joined 2cureX?s Clinical Advisory Board. Dr. Andrew Beggs is Professor of Cancer Genetics & Surgery in the Institute of Cancer and Genomic Sciences and Co-Lead of Molecular Oncology, Pathology and Genetics, University of Birmingham, UK. He is also Head of West Midlands GI & Gynecology Cancer Tumor Board Cancer Research UK & RCSEng Advanced Clinician Scientist, Consultant Colorectal & General Surgeon. Dr. Andrew Beggs is also Research Director for cancer in the NHS (National Health Service) South and Central Genomic Medicine Service Alliance.